Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0882420120830020287
Korean Journal of Medicine
2012 Volume.83 No. 2 p.287 ~ p.290
A Case of Anti-Cyclic Citrullinated Peptide Antibody-Positive Rheumatoid Arthritis Following Peginterferon Alpha-2A and Ribavirin Therapy for Chronic Hepatitis C
Kim Dong-Hyun

Kim Young-Hwan
Lee Soon-Il
Ha Byung-Kil
Choi Seong-Ho
Kim Sung-Il
Lee Jung-Wook
Abstract
Combination therapy with pegylated interferon (IFN) and ribavirin is the mainstay of treatment for chronic hepatitis C. An important side effect of IFN is the induction of an autoimmune disease such as autoimmune thyroid disease or, rarely, rheumatoid arthritis. However, the introduction of pegylated formulations of IFN can minimize the risk of autoimmune induction by reducing immunogenicity. Detection of anti-cyclic citrullinated peptide (anti-CCP) antibodies can help distinguish rheumatoid arthritis from hepatitis C-related arthritis. Here, we report the first Korean case of a 48-year-old female who developed anti-CCP antibodypositive rheumatoid arthritis following peginterferon alpha-2a therapy for hepatitis C.
KEYWORD
Arthritis, Rheumatoid, Hepatitis C, Chronic, Peginterferon alpha-2a
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø